Activity Preview

Live

Choosing the Right Treatment for Substance Use Disorders

Activity Type:

  • On Demand


Release Date: 8/20/2015

Expiration Date: 8/20/2018

  • AMA PRA Category 1 Physician: 2.5
  • Participation: 2.5

Access Activity

Overview

Substance use disorders remain a major public health problem with financial costs and important implications for health and criminal justice systems. Shifts continue to occur in cost, purity, and geographic spread of various agents. The fastest growing problem is hazardous use of stimulants and prescription opioids, along with a recent rise in heroin use, while cocaine use remains endemic, methamphetamine use has decreased, marijuana has higher potency and greater availability, and marijuana use has lower age of onset. The course combines current scientific knowledge with discussion of the most efficacious treatments for all of these agents, as well as strategies to manage patients with comorbid pain. Emphasis is on office-based approaches, and courses include discussion of both pharmacological and psychological treatment methods. The speakers are nationally recognized experts in substance use disorders and will discuss practical and cutting edge treatments.

**This content was captured at the 2014 APA Annual Meeting

Pricing

  • General Member - $31.25
  • Resident-Fellow Member - Free
  • Medical Student Member - $31.25
  • Non-Member - $62.50

Educational Objectives

  • Recognize clinical signs and symptoms of abuse of sedative-hypnotic or stimulant medications
  • Identify strategies to manage patients, and recognize risks/benefits of prescribing these medications 
  • Describe the problem of opioid abuse among chronic pain patients and be aware of screening tools to reduce likelihood of abuse
  • List pharmacological approaches to manage pain in high-risk patients

Target Audience

Residents/Fellows and Psychiatrists

Estimated Time to Complete

2.5 Hours

How to Earn Credit

Participants who wish to earn AMA PRA Category 1 Credit ™ or a certificate of participation may do so by completing all sections of the course including the evaluation. A multiple choice quiz is provided based on the content. A passing score of 50% must be achieved. Retakes are available for the test. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the date of completion and hours earned. 

Accreditation

The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The APA designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty and Planner Disclosures

Chair

  • Herbert D. Kleber, M.D., Columbia University | Disclosure: Consultant/Advisory Board - Grunenthal GmBH
  • Edward V. Nunes, M.D., Columbia University/New York State Psychiatric Institute | Disclosure: Grant/Research Support - Alkermes | Cephalon Inc. | Reckitt Benckiser Pharmaceuticals | Duramed Pharmaceuticals | HealthSim, LLC | Brainsway Inc | Other - Dr. Nunes receives medication for research studies from Alkermes/Cephalon, Inc., receives placebo and medication for research studies from Reckitt-Benckiser, and has received medication for research study from Duramed Pharmaceuticals; HealthSim, LLC has supplied a web-based behavioral intervention for one of his research studies. Dr. Nunes has received or will receive from Brainsway devices under investigation and reimbursement for travel expenses for investigators' meeting as part of research.

Presenters

  • Adam Bisaga, M.D., Columbia University/New York State Psychiatric Institute | Disclosure: Reports no financial relationships with commercial interests
  • John J. Mariani, M.D., Columbia University/New York State Psychiatric Institute | Disclosure: Reports no financial relationships with commercial interests
  • Maria A. Sullivan, M.D., Ph.D., Columbia University/New York State Psychiatric Institute | Disclosure: Grant/Research Support Reckitt Benckiser Pharmaceuticals | Other - Receives medication for research study from Alkermes/Cephalon, Inc.
  • Edward V. Nunes, M.D., Columbia University/New York State Psychiatric Institute | Disclosure: Grant/Research Support - Alkermes | Cephalon Inc. | Reckitt Benckiser Pharmaceuticals | Duramed Pharmaceuticals|HealthSim, LLC | Brainsway Inc | Other - Dr. Nunes receives medication for research studies from Alkermes/Cephalon, Inc., receives placebo and medication for research studies from Reckitt-Benckiser, and has received medication for research study from Duramed Pharmaceuticals; HealthSim, LLC has supplied a web-based behavioral intervention for one of his research studies. Dr. Nunes has received or will receive from Brainsway devices under investigation and reimbursement for travel expenses for investigators' meeting as part of research.

Program Planners:

  • Tristan Gorrindo, M.D., Director of Education, American Psychiatric Association | Disclsoure: Reports no financial relationships with commercial interests
  • Ricardo Juarez, Associate Director, Office of International Affairs, American Psychiatric Association | Disclosure: Reports no financial relationships with commercial interests

Hardware/Software Requirements

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration

  • Flash Player: Adobe Flash Player 10.1+ 
  • Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+ 
  • Operating System: Windows XP+ or Mac OS X 10.4+ 
  • Internet Connection: 1 Mbps or higher

Minimum Requirements

  • Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
  • Macintosh:  Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit

For assistance: Contact educme@psych.org for questions about this course | Contact learningcenter@psych.org for technical assistance

Access Activity